Added to YB: 2024-08-20
Pitch date: 2024-07-15
TEVA [bullish]
Teva Pharmaceutical Industries Limited
+73.6%
current return
Author Info
No bio for this author
Company Info
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.
Market Cap
$30.7B
Pitch Price
$17.16
Price Target
N/A
Dividend
N/A
EV/EBITDA
9.65
P/E
43.30
EV/Sales
2.72
Sector
Pharmaceuticals
Category
turnaround
Invesco EQV International Equity Fund New Position: Teva Pharmaceutical Industries Limited
TEVA: Global pharma leader in generics, biosimilars & specialty drugs. Growing branded pipeline. Mgmt forecasts accelerating revenue growth, rising margins, lower leverage. Valuation multiple has upside potential. Improving earnings & quality story post-transformation.
Read full article (1 min)